InvestorsHub Logo
Followers 2
Posts 113
Boards Moderated 0
Alias Born 10/05/2018

Re: None

Saturday, 01/19/2019 12:16:31 PM

Saturday, January 19, 2019 12:16:31 PM

Post# of 32923
NCM Biotech is going to take KALY to a medical level not many see coming:

Beech Tree Labs management brings to bear highly refined expertise in business management, scientific research and development, strategic thinking, and industry-wide collaborations. This seasoned team has demonstrated a track record of success in moving products from concept to licensing as evidenced by 16 FDA-authorized clinical trials, 4 IRB-approved trials, 2 USDA-approved trials, 30+ patents licensed to Elan Corp, plc, a nutraceutical respiratory health product licensed to Allergy Research Group, and a prescription veterinary product licensed to Eudaemonic Corp.

Current management for Beech Tree Labs includes:

John McMichael, Ph.D., President & CEO
Dr. McMichael developed the world’s first live-virus fish vaccines for use in fish populations, and is an Alzheimer’s disease pioneer, having licensed 30+ patents to Elan Corp. plc, to support their Alzheimer’s initiative. He now holds more than 100 patents with twice that pending worldwide. His experience also includes:

Post-doctoral research associate, The Wistar Institute;
Professor of Biology and Health Sciences, Edinboro University of Pennsylvania;
General Manager for ImmunoTherapeutics, where he licensed a veterinary anti-inflammatory product to Eudomonics, Inc., which launched and continues to sell the product;
Vice President of Molecular Rx, Inc., a biopharmaceutical company focused on products for managing inflammatory responses;
Founder and President of Milkhaus Laboratory, Inc., a company now focused on botanical agents for nutraceutical use;

I will hold as long as it takes. Big things are coming from their clinical trials involving their patented CBD extraction involving COPD pain management in the near future.